Drug Type Autologous CAR-T |
Synonyms ssCART-19, ssCART-19 cells, ssCART-19(Shanghai Unicar) + [1] |
Target |
Mechanism CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors) |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationOrphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
CD19-positive B-cell acute lymphoblastic leukemia | Phase 2 | CN | 08 Apr 2024 | |
CD19 positive Acute Lymphoblastic Leukemia | Phase 2 | CN | 01 Apr 2024 | |
B-Cell Leukemia | Phase 1 | CN | 09 Apr 2021 | |
Refractory Adult Acute Lymphoblastic Leukemia | Phase 1 | CN | 09 Apr 2021 | |
Refractory Adult Acute Lymphoblastic Leukemia | Phase 1 | CN | 09 Apr 2021 |
Phase 1 | 13 | dsygjoinsq(kymznyoceo) = 9 patients (75.0%) developed CRS, and 3 patients (25.0%) were grade 3 CRS gnpeyvkwqm (zplsjhlrpy ) View more | - | 10 Dec 2023 |